Exponential Repulsion Improves Structural Predictability of Molecular Docking

被引:8
作者
Bazgier, Vaclav [1 ,2 ]
Berka, Karel [3 ]
Otyepka, Michal [3 ]
Banas, Pavel [3 ]
机构
[1] ASCR, Inst Expt Bot, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 11, Olomouc 78371, Czech Republic
[2] Palacky Univ, Slechtitelu 11, Olomouc 78371, Czech Republic
[3] Palacky Univ, Fac Sci, Dept Phys Chem, Reg Ctr Adv Technol & Mat, 17 Listopadu 12, Olomouc 77146, Czech Republic
关键词
molecular docking; DOCK; 6.6; drug design; cyclin-dependent kinase 2; directory of decoys; STRUCTURE-BASED DESIGN; SCORING FUNCTIONS; FORCE-FIELD; CDK2; INHIBITORS; PURINE; POTENT; DISCOVERY; ALGORITHMS; ASSIGNMENT; FAMILY;
D O I
10.1002/jcc.24473
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Molecular docking is a powerful tool for theoretical prediction of the preferred conformation and orientation of small molecules within protein active sites. The obtained poses can be used for estimation of binding energies, which indicate the inhibition effect of designed inhibitors, and therefore might be used for in silico drug design. However, the evaluation of ligand binding affinity critically depends on successful prediction of the native binding mode. Contemporary docking methods are often based on scoring functions derived from molecular mechanical potentials. In such potentials, nonbonded interactions are typically represented by electrostatic interactions between atom-centered partial charges and standard 6-12 Lennard-Jones potential. Here, we present implementation and testing of a scoring function based on more physically justified exponential repulsion instead of the standard Lennard-Jones potential. We found that this scoring function significantly improved prediction of the native binding modes in proteins bearing narrow active sites such as serine proteases and kinases. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:2485 / 2494
页数:10
相关论文
共 50 条
[1]   A computational study of the protein-ligand interactions in CDK2 inhibitors:: Using quantum mechanics/molecular mechanics interaction energy as a predictor of the biological activity [J].
Alzate-Morales, Jans H. ;
Contreras, Renato ;
Soriano, Alejandro ;
Tunon, Inaki ;
Silla, Estanislao .
BIOPHYSICAL JOURNAL, 2007, 92 (02) :430-439
[2]  
[Anonymous], R SOC PHYS SCI RES J
[3]  
[Anonymous], INT SER MONOGRAPHS C
[4]   Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles [J].
Arris, CE ;
Boyle, FT ;
Calvert, AH ;
Curtin, NJ ;
Endicott, JA ;
Garman, EF ;
Gibson, AE ;
Golding, BT ;
Grant, S ;
Griffin, RJ ;
Jewsbury, P ;
Johnson, LN ;
Lawrie, AM ;
Newell, DR ;
Noble, MEM ;
Sausville, EA ;
Schultz, R ;
Yu, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (15) :2797-2804
[5]   Can We Accurately Describe the Structure of Adenine Tracts in B-DNA? Reference Quantum-Chemical Computations Reveal Overstabilization of Stacking by Molecular Mechanics [J].
Banas, Pavel ;
Mladek, Arnost ;
Otyepka, Michal ;
Zgarbova, Marie ;
Jurecka, Petr ;
Svozil, Daniel ;
Lankas, Filip ;
Sponer, Jiri .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (07) :2448-2460
[6]   CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases [J].
Bettayeb, K. ;
Oumata, N. ;
Echalier, A. ;
Ferandin, Y. ;
Endicott, J. A. ;
Galons, H. ;
Meijer, L. .
ONCOGENE, 2008, 27 (44) :5797-5807
[7]   Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis [J].
Bramson, HN ;
Corona, J ;
Davis, ST ;
Dickerson, SH ;
Edelstein, M ;
Frye, SV ;
Gampe, RT ;
Harris, PA ;
Hassell, A ;
Holmes, WD ;
Hunter, RN ;
Lackey, KE ;
Lovejoy, B ;
Luzzio, MJ ;
Montana, V ;
Rocque, WJ ;
Rusnak, D ;
Shewchuk, L ;
Veal, JM ;
Walker, DH ;
Kuyper, LF .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4339-4358
[8]   Discovery of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino) pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity [J].
Chu, Xin-Jie ;
DePinto, Wanda ;
Bartkovitz, David ;
So, Sung-Sau ;
Vu, Binh T. ;
Packman, Kathryn ;
Lukacs, Christine ;
Ding, Qingjie ;
Jiang, Nan ;
Wang, Ka ;
Goelzer, Petra ;
Yin, Xuefeng ;
Smith, Melissa A. ;
Higgins, Brian X. ;
Chen, Yingsi ;
Xiang, Qing ;
Moliterni, John ;
Kaplan, Gerald ;
Graves, Bradford ;
Lovey, Allen ;
Fotouhi, Nader .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (22) :6549-6560
[9]   Highlights of the Latest Advances in Research on CDK Inhibitors [J].
Cicenas, Jonas ;
Kalyan, Karthik ;
Sorokinas, Aleksandras ;
Jatulyte, Asta ;
Valiunas, Deividas ;
Kaupinis, Algirdas ;
Valius, Mindaugas .
CANCERS, 2014, 6 (04) :2224-2242
[10]   A 2ND GENERATION FORCE-FIELD FOR THE SIMULATION OF PROTEINS, NUCLEIC-ACIDS, AND ORGANIC-MOLECULES [J].
CORNELL, WD ;
CIEPLAK, P ;
BAYLY, CI ;
GOULD, IR ;
MERZ, KM ;
FERGUSON, DM ;
SPELLMEYER, DC ;
FOX, T ;
CALDWELL, JW ;
KOLLMAN, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5179-5197